Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model. - Test2 - elhamkhani - TriplyDB

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

http://www.wikidata.org/entity/Q33569173

about

Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century Neuroprotection by spice-derived nutraceuticals: you are what you eat!Nutraceuticals in Parkinson's Disease Plant-derived neuroprotective agents in Parkinson's disease Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's disease Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates Curcumin's neuroprotective efficacy in Drosophila model of idiopathic Parkinson's disease is phase specific: implication of its therapeutic effectiveness.Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease.Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice Curcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic Mice TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis.Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases Curcumin Protects against 1-Methyl-4-phenylpyridinium Ion- and Lipopolysaccharide-Induced Cytotoxicities in the Mouse Mesencephalic Astrocyte via Inhibiting the Cytochrome P450 2E1.Mitochondrial metals as a potential therapeutic target in neurodegeneration.Molecular chaperones and associated cellular clearance mechanisms against toxic protein conformers in Parkinson's disease.Multifaceted roles of curcumin: two sides of a coin!Curcumin and neurodegenerative diseases: a perspective.Copper as a key regulator of cell signalling pathways.Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.Structural, morphological, and functional diversity of amyloid oligomers.α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.Curcumin Rescues a PINK1 Knock Down SH-SY5Y Cellular Model of Parkinson's Disease from Mitochondrial Dysfunction and Cell Death.Investigating dynamic structural and mechanical changes of neuroblastoma cells associated with glutamate-mediated neurodegeneration.α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease.Atomic force microscopy as an advanced tool in neuroscience.Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties.Indian Herbs for the Treatment of Neurodegenerative Disease.Curcumin modulates α-synuclein aggregation and toxicity.Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.Effect of curcumin on lifespan, activity pattern, oxidative stress, and apoptosis in the brains of transgenic Drosophila model of Parkinson's disease.Curcumin inhibits apoptosis by regulating intracellular calcium release, reactive oxygen species and mitochondrial depolarization levels in SH-SY5Y neuronal cells.Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms Curcumin modulates cell death and is protective in Huntington's disease model.A sensitive phage-based capture ELISA for sub-femtomolar detection of protein variants directly from biological samples.Synthesis of alginate-curcumin nanocomposite and its protective role in transgenic Drosophila model of Parkinson's disease Alpha-synuclein oligomers: a new hope.

P2860

Q24311960-FEBEE95E-A0EF-4F14-ADE7-77494B2A3013 Q24630927-CED98F3B-61D5-4095-AC75-D5FB0DE8C239 Q24635358-E88C99CD-73C2-4BFE-A0C7-2C65955077AE Q26752769-24B5D8F1-2CD4-4681-B20A-B22FCB85EC2B Q26795546-EC787F99-C539-4977-AB9D-E7C8B18B526A Q27023467-D0634131-8A0B-42C4-B39C-F033FBE94E60 Q28259424-2184DB3E-4833-436C-9418-88A23B670EEB Q28389419-609A27A3-2608-4220-862D-E2BD2232FEFD Q34074933-EA23AFD8-9AC5-436F-B82D-72CDE513070E Q34729680-8AF35914-FA54-41E9-A4EC-CBF96A3B8F69 Q34983243-02C0B222-269E-4FAF-9721-3DDD2C56D2B8 Q35054395-39790118-3E8A-4065-89E1-04FEB981A773 Q35606190-633E6CFF-3C64-4522-BE31-AF9A97689782 Q35650069-106590E7-B717-44EE-ADC7-A6662910C8E6 Q36260146-000924FF-AB68-4BC0-8C64-F5332821A937 Q36479597-64B8CE3A-4E94-4944-89E6-FCBED1DAEB39 Q36988551-A0219110-E024-4741-9467-E1592A5A7FD6 Q37686294-BCC8EE9B-06E6-4874-986F-87DBA36558F0 Q37853789-8D0F6D95-CD74-4234-A419-E2CFF5346055 Q37937617-4E38EE66-49D0-4BD5-8267-9B946C670751 Q38016212-389FD0A2-62F8-4984-9275-7B257A649737 Q38213536-3723DAF6-2F50-4BE7-98C8-B47C30673358 Q38213838-54366CC3-5789-4DB8-8A8F-422E72F75BE4 Q38549882-44655E3C-88E1-4390-8B40-E9315139CAC4 Q38669019-D721DC00-FFCA-4D9B-B9A4-9E25E6974B47 Q38784071-09ACB7A1-2101-4C21-B302-6013CF55A7DA Q38940235-22A42FA1-BF28-4AF6-B5F9-13E3835E3283 Q38947516-25948B0E-2C11-4C29-81DD-B611AEE082FA Q38998492-030996AF-4950-4EE5-A3DC-83006C3BAD1F Q39156104-539790CD-FE3F-44F6-815F-FBE3E18DDCBA Q39167139-EAF3328C-E987-49D9-AFDF-7AFEE8245514 Q39178579-EA1CB3ED-A6C7-4F95-A76B-3A751F736A15 Q39209459-06D401DE-B8C0-4850-B218-CC1657AC8CEA Q39467871-016E44B6-DB35-4A64-9230-63E86556F897 Q40273636-33682791-BA7F-4116-A6C3-F616502B54A5 Q41622472-37C0C5E3-A0B4-4A01-AD4E-CEF67A61BCC6 Q41814213-6E980A83-7248-4BBE-94F8-7E61674BFCEB Q42190840-DD417F45-25E1-4E2F-87B7-916B931941AE Q42655220-868E49BB-6D7B-4BFF-88C2-2310971D891E Q46321755-63B5920F-D23A-4145-BA87-5FAD46C37169

P2860

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

http://www.wikidata.org/entity/Q33569173

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@ast

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@en

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@nl

type

label

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@ast

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@en

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@nl

prefLabel

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@ast

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@en

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@nl

P1433

Q33569173-423D407A-03D5-40D2-98B0-F1DF00966261

P1476

Q33569173-7A1435D9-730A-4EF1-B6BA-186DB8E25ECD

P2093

Q33569173-601B5BC7-E68F-49CB-AED5-D644D592EE6F

Q33569173-8C50157A-9AEA-4A32-8350-76701DA3BE5C

Q33569173-D3E5AEF5-2CDB-486A-BB7B-BCAD4E983F55

P2860

Q33569173-0158C84A-0A2A-4F25-B5BB-D3490026E35E

Q33569173-0A6642F8-5C3D-48F6-A0E7-2DD1A87CB088

Q33569173-0E5EE27C-9028-44BA-AFC1-FB3EAEB30AA5

Q33569173-10C534FA-5EB2-4712-B2DA-1A50A13B482D

Q33569173-1263C2FD-D599-4BFE-A21E-D707C2A0B76E

Q33569173-12FD8A64-D378-4D49-8D01-D46C115F647A

Q33569173-16A4D1E1-D4D5-499A-90C6-CDB17AAEA4C4

Q33569173-1D6FF09C-85F6-4780-89F8-0EC352C162C6

Q33569173-247B0390-F4E4-42CC-99E9-07DD3B8F0C1A

Q33569173-272CB6A0-FBE0-40BE-8B7C-D27B0D3DA5A9

P2888

Q33569173-940DB389-4AFA-44BB-8A66-F1EE696CF6A7

P304

Q33569173-8859E7EA-F69A-44DC-BC07-29F0F0D109EB

P31

Q33569173-BF063505-73EE-4D9C-A96D-0D6B12AEE760

P356

Q33569173-465DAB92-9A83-4A64-9E9B-DC3545BBA1DD

P478

Q33569173-FF8D0FC2-B96F-4205-A4E1-FA3BE9FA8161

P50

Q33569173-92499BD0-797B-4737-8111-F5B8C89B8C5F

P577

Q33569173-F941F0A9-4D27-4489-BDFE-7231AD837E4F

P5875

Q33569173-E7A4D0E9-DB30-4FAE-95A9-5D816BDB5757

P6179

Q33569173-95CFFCB4-E1DC-4D69-A192-92AF70970A89

P698

Q33569173-3BEBA083-412F-4BF0-AD97-1EF755616F55

P921

Q33569173-02AF42ED-1FFB-4F31-8598-8070139FD3A0

Q33569173-43DF1BAD-48CA-45B2-B5BA-CCDE5F28E882

Q33569173-4b068392-5075-46b5-bc73-565f6ff9b10a

Q33569173-A349B4BC-904B-4E9D-8BC2-4722EF8AE684

P932

Q33569173-0FA9E9E8-0DD7-4668-BDFA-58D1199C1E64

P356

1471-2202-11-57

P1433

BMC Neuroscience

P1476

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

@en

P2093

Michael R Sierks

http://www.w3.org/2001/XMLSchema#string

Shanta Boddapati

http://www.w3.org/2001/XMLSchema#string

Sharareh Emadi

http://www.w3.org/2001/XMLSchema#string

P2860

Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

alpha-Synuclein locus triplication causes Parkinson's disease

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

A Drosophila model of Parkinson's disease

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.

Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity

Curcumin inhibits aggregation of alpha-synuclein.

P2888

1471-2202-11-57

P304

57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2202-11-57

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43532780

http://www.w3.org/2001/XMLSchema#string

P6179

1023043810

http://www.w3.org/2001/XMLSchema#string

P698

20433710

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2879277

http://www.w3.org/2001/XMLSchema#string